Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial

Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial

ABSTRACT Accumulating evidence implicates gut microbiota as promising targets for the treatment of type 2 diabetes mellitus (T2DM). With a randomized clinical trial, we tested the hypothesis that alteration of gut microbiota may be involved in the alleviation of T2DM with hyperlipidemia by metformin...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaolin Tong, Jia Xu, Fengmei Lian, Xiaotong Yu, Yufeng Zhao, Lipeng Xu, Menghui Zhang, Xiyan Zhao, Jian Shen, Shengping Wu, Xiaoyan Pang, Jiaxing Tian, Chenhong Zhang, Qiang Zhou, Linhua Wang, Bing Pang, Feng Chen, Zhiping Peng, Jing Wang, Zhong Zhen, Chao Fang, Min Li, Limei Chen, Liping Zhao
Format: article
Language:EN
Published: American Society for Microbiology 2018
Subjects:
clinical trial
gut microbiota
hyperlipidemia
metformin
traditional Chinese medicine
type 2 diabetes
Microbiology
QR1-502
Online Access:https://doaj.org/article/4bbfd07147a640af843e25626e98dcb6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/4bbfd07147a640af843e25626e98dcb6

Similar Items